1-3 of 3
Patricia A. Steele, RN, BSN
Close
Sort by
Journal Articles

Induction Of Anti-Myeloma Cellular and Humoral Immunity By Pre-Targeting Clonogenic Myeloma Cells Prior To Stem Cell Transplant With T Cells Armed With Anti-CD3 x Anti-CD20 Bispecific Antibody Leads To Transfer Of Cellular and Humoral Anti-Myeloma Immunity

Lawrence G Lum, MD, DSc, Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Abhinav Deol, MBBS, MD, Lois Ayash, MD, Elyse N. Tomaszewski, BA, Hiroshi Yano, BS, Dana L Schalk, BS, MBA, Sri Vidya Kondadasula, MS, Patricia A. Steele, RN, BSN, Jeffrey A. Zonder, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Muneer H. Abidi, MD
Journal: Blood
Blood (2013) 122 (21): 139.
https://doi.org/10.1182/blood.V122.21.139.139
Published: 2013
Journal Articles

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Cassara Pray, BS, Elyse N. Tomaszewski, BA, Ritesh Rathore, MD, Patricia A. Steele, RN, BSN, Muneer H. Abidi, MD, Lois Ayash, MD, Dana L Schalk, BS, MBA, Karen Myers, BSN, OCN, Alice Mitchell, BS, Abhinav Deol, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc
Journal: Blood
Blood (2011) 118 (21): 1914.
https://doi.org/10.1182/blood.V118.21.1914.1914
Published: 2011
Journal Articles

Phase I Dose Esclation of Activated T Cells (ATC) Armed with Anti-CD3 × Anti-CD20 Bispecific Antibody (CD20Bi) after Stem Cell Transplant (SCT) In Non-Hodgkin's Lymphoma (NHL)

Lawrence G. Lum, MD, DSc, Voravit Ratanatharathorn, MD, Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Cassara Skuba, BS, Elyse N. Paul, BA, Patricia A. Steele, RN, BSN, Lois Ayash, MD, Muneer H. Abidi, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 488.
https://doi.org/10.1182/blood.V116.21.488.488
Published: 2010